Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Healthy women between 18 and 40 requesting oral contraception~Exclusion Criteria:~- The use of steroidal oral contraceptives, or any drug that could alter Oral Contraception metabolism will be prohibited during the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Drospirenone (DRSP)/Ethinylestradiol (EE)/Metafolin (MTHF) (Type: EXPERIMENTAL): 1 tablet 0.020 mg EE/3.0 mg DRSP/0.451 mg L-5-MTHF as calcium salt given orally/daily for 24 days followed by 1 tablet 0.451 mg L-5-MTHF as calcium salt given orally/daily for 4 days over a time period of 24 weeks
- Drospirenone (DRSP)/Ethinylestradiol (EE) (Type: ACTIVE_COMPARATOR): 1 tablet 0.020 mg EE/3.0 mg DRSP \[YAZ\] given orally/daily for 24 days followed by 1 placebo tablet given orally/daily for 4 days over a time period of 24 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).